The Prevalence of Diabetic Retinopathy among Adults in the United States

Archives of Ophthalmology

Volumn 122, Issue 4, 2004, Pages 552-563

  Kempen, John H ^a,b,k   O'Colmain, Benita J ^c,d   Leske, M Cristina ^e   Haffner, Steven M ^f   Klein, Ronald ^g   Moss, Scot E ^g   Taylor, Hugh R ^h   Hamman, Richard F ⁱ   West, Sheila K ^a,b   Wang, Jie Jin ^j   Congdon, Nathan G ^a,b   Friedman, David S ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^d MACRO INTERNATIONAL INC   (United States)

^e STONY BROOK UNIVERSITY   (United States)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^g UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF SYDNEY   (Australia)

^k NONE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RETINA MACULA EDEMA; UNITED STATES; VISION;

EID: 11144356305     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.122.4.552     Document Type: Article

References (47)

1. American Academy of Ophthalmology. Preferred Practice Pattern: Diabetic Retinopathy. San Francisco, Calif: American Academy of Ophthalmology; 1998.
2. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, II: prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102:520-526.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
4. Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia. 2001;44:156-163.
5. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 [published erratum appears in BMJ. 1999;318:29]. BMJ. 1998;317:703-713.
6. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 [published erratum appears in BMJ. 1999;318:29]. BMJ. 1998;317:703-713.
7. Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int. 2002;61:1086-1097.
8. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS report number 12. Ophthalmology. 1991;98(suppl):823-833.
9. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the modified Airlie House classification: ETDRS report number 10. Ophthalmology. 1991;98(suppl):786-806.
10. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, III: prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102:527-532.
11. Klein R, Klein BE, Moss SE, Linton KL. The Beaver Dam Eye Study: retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology. 1992;99:58-62.
12. Leske MG, Wu SY, Hyman L, et al. Diabetic retinopathy in a black population: the Barbados Eye Study. Ophthalmology. 1999;106:1893-1899.
13. Mitchell P, Smith W, Wang JJ, Attebo K. Prevalence of diabetic retinopathy in an older community: the Blue Mountains Eye Study. Ophthalmology. 1998;105:406-411.
14. West SK, Klein R, Rodriguez J, et al. Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. Diabetes Care. 2001;24:1204-1209.
15. Haffner SM, Hazuda HP, Stern MP, Patterson JK, Van Heuven WA, Fong D. Effects of socioeconomic status on hyperglycemia and retinopathy levels in Mexican Americans with NIDDM. Diabetes Care. 1989;12:128-134.
16. Hamman RF, Mayer EJ, Moo-Young GA, Hildebrandt W, Marshall JA, Baxter J. Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM: San Luis Valley Diabetes Study. Diabetes. 1989;38:1231-1237.
17. McKay R, McCarty CA, Taylor HR. Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project. Br J Ophthalmol. 2000;84:865-870.
18. The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study (DRS) findings: DRS report number 8. Ophthalmology. 1981;88:583-600.
19. Schachat AP, Hyman L, Leske MC, et al, for the Barbados (West Indies) Eye Study Group. Comparison of diabetic retinopathy detection by clinical examinations and photograph gradings. Arch Ophthalmol. 1993;111:1064-1070.
20. 1999 National Health Interview Survey (NHIS) Public Use Data Release. NHIS Survey Description. Division of Health Interview Statistics NCHS. Available at: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/1999/ srvydesc.pdf. Accessed September 30, 2002.
21. US Census 2000 Population Tables were obtained from: US Census 2000 Summary File 1 (SF 1) 100-Percent Data. Available at: http://factfinder.census.gov/servlet/DatasetMainPageServlet?_lang=en. Accessed January 1, 2003.
22. Lachin JM. Biostatistical Methods. New York, NY: John Wiley & Sons Inc; 2000.
23. Boyle JP, Honeycutt AA, Narayan KM, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the US. Diabetes Care. 2001;24:1936-1940.
24. Ferris FL III. How effective are treatments for diabetic retinopathy? JAMA. 1993;269:1290-1291.
25. The Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477-485.
26. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care. 2000;23:381-389.
27. Roy MS, Klein R, O'Colmain BJ, et al. The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States. Arch Ophthalmol. 2004;122:546-551.
28. Kahn HA, Moorhead HB. Statistics on Blindness in the Model Reporting Area, 1969-1970. Washington, DC: National Eye Institute, Superintendent of Documents, US Government Printing Office; 1973. NIH publication 73-427.
29. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, X: four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol. 1989;107:244-249.
30. Klein R, Klein BE, Moss SE, Cruickshanks KJ. Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol. 1999;117:1487-1495.
31. Harris MI, Klein R, Cowie CC, Rowland M, Byrd-Holt DD. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? a US population study. Diabetes Care. 1998;21:1230-1235.
32. Klein R, Barrett-Connor EL, Blunt BA, Wingard DL. Visual impairment and retinopathy in people with normal glucose tolerance, impaired glucose tolerance, and newly diagnosed NIDDM. Diabetes Care. 1991;14:914-918.
33. Klein R, Klein BEK. Vision disorders in diabetes. In: National Diabetes Data Group, ed. Diabetes in America. Bethesda, Md: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; 1995:293-338. NIH publication 95-1468.
34. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, IX: four- year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1989;107:237-243.
35. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, XIV: ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994;112:1217-1228.
36. Haffner SM, Fong D, Stern MP, et al. Diabetic retinopathy in Mexican Americans and non-Hispanic whites. Diabetes. 1988;37:878-884.
37. Harris MI, Robbins DC. Prevalence of adult-onset IDDM in the US population. Diabetes Care. 1994;17:1337-1340.
38. The Diabetes Control and Complications Trial. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol. 1995;113:36-51.
39. Diabetic retinopathy study. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy Study Group. Invest Ophthalmol Vis Sci. 1981;21(pt 2):210-226.
40. Moss SE, Meuer SM, Klein R, Hubbard LD, Brothers RJ, Klein BE. Are seven standard photographic fields necessary for classification of diabetic retinopathy? Invest Ophthalmol Vis Sci. 1989;30:823-828.
41. Chiang YP, Bassi LJ, Javitt JC. Federal budgetary costs of blindness. Milbank Q. 1992;70:319-340.
42. Javitt JC, Aiello LP, Bassi LJ, Chiang YP, Canner JK, for American Academy of Ophthalmology, Detecting and treating retinopathy in patients with type I diabetes mellitus: savings associated with improved implementation of current guidelines. Ophthalmology. 1991;98:1565-1573.
43. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865.
44. British Multicentre Study Group. Photocoagulation for diabetic maculopathy: a randomized controlled clinical trial using the xenon arc. Diabetes. 1983;32:1010-1016.
45. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study Report Number 1. Arch Ophthalmol. 1985;103:1796-1806.
46. Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med. 1996;124(pt 2):164-169.
47. Kraft SK, Marrero DG, Lazaridis EN, Fineberg N, Qiu C, Clark CM Jr. Primary care physicians' practice patterns and diabetic retinopathy: current levels of care. Arch Fam Med. 1997;6:29-37.